有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | (2R)-2-(2-chlorophenyl)sulfanyl-N-[(2-morpholin-4-ylpyridin-4-yl)methyl]propanamide | —— | C19H22ClN3O2S |
|
—— | (2R)-2-(2-chlorophenyl)sulfanyl-N-(furan-2-ylmethyl)-N-(2-methoxyethyl)propanamide | —— | C17H20ClNO3S |
|
—— | (2S)-N-[(3S)-1,1-dioxothiolan-3-yl]-N-methyl-2-[5-(trifluoromethyl)pyridin-2-yl]sulfanylpropanamide | —— | C14H17F3N2O3S2 |
|
—— | 2-[[5-[[(3S)-1,1-dioxothiolan-3-yl]methyl]-4-methyl-1,2,4-triazol-3-yl]sulfanyl]-N-[(2S)-5-methylhexan-2-yl]acetamide | —— | C17H30N4O3S2 |
|
—— | 2-[[5-[[(3R)-1,1-dioxothiolan-3-yl]methyl]-4-methyl-1,2,4-triazol-3-yl]sulfanyl]-N-[(2S)-5-methylhexan-2-yl]acetamide | —— | C17H30N4O3S2 |
|
—— | (2S)-2-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanyl]-N,N-di(propan-2-yl)propanamide | —— | C17H26N4O2S |
|
—— | 7-[[5-cyclopropyl-4-(furan-2-ylmethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-2-ethyl-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one | —— | C18H18N6O2S2 |
|
—— | (2R)-2-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanyl]-N,N-di(propan-2-yl)propanamide | —— | C17H26N4O2S |
|
—— | 5-[(5-chlorothiadiazol-4-yl)methylsulfanyl]-3-(4-fluorophenyl)-1,3,4-thiadiazole-2-thione | —— | C11H6ClFN4S4 |
|
—— | [2-(cycloheptylamino)-2-oxoethyl] (2S)-2-propan-2-ylsulfonylpropanoate | —— | C15H27NO5S |
|
—— | 2-(2,5-dimethylpyrazol-3-yl)sulfanyl-N-[(3S)-2-methyl-4-oxopentan-3-yl]acetamide | —— | C13H21N3O2S |
|
—— | (2S)-2-amino-3-(2,5-dimethylpyrazol-3-yl)sulfanylpropanenitrile | —— | C8H12N4S |
|
—— | [(1S,2R,4R)-2-(2,5-dimethylpyrazol-3-yl)sulfanyl-4-propylcyclohexyl]methanamine | —— | C15H27N3S |
|
—— | (2R)-2-(2,5-dimethylpyrazol-3-yl)sulfanyl-2-(1-methylpyrazol-4-yl)ethanamine | —— | C11H17N5S |
|
—— | (2S)-2-(2,5-dimethylpyrazol-3-yl)sulfanyl-2-(furan-2-yl)ethanamine | —— | C11H15N3OS |
|
—— | (2S)-2-(2,5-dimethylpyrazol-3-yl)sulfanylbutan-1-amine | —— | C9H17N3S |
|
—— | (2S)-3-(2,5-dimethylpyrazol-3-yl)sulfanyl-2-methyl-2-(methylamino)propanenitrile | —— | C10H16N4S |
|
—— | (1R,2R)-1-(2,5-dimethylpyrazol-3-yl)sulfanyl-1-thiophen-2-ylbutan-2-amine | —— | C13H19N3S2 |
|
—— | 2-[1-[(3S)-2-methylpentan-3-yl]-4-oxopyrimidin-2-yl]sulfanylacetic acid | —— | C12H18N2O3S |
|
—— | 2-[1-[(3R)-2-methylpentan-3-yl]-4-oxopyrimidin-2-yl]sulfanylacetic acid | —— | C12H18N2O3S |
|
—— | (2R)-2-(2,5-dimethylpyrazol-3-yl)sulfanyl-3-methylbutanoic acid | —— | C10H16N2O2S |
|
—— | [(1S,2S)-2-(2,5-dimethylpyrazol-3-yl)sulfanylcyclopentyl]methanamine | —— | C11H19N3S |
|
—— | 2-[1-[(2S)-4-methylpentan-2-yl]-4-oxopyrimidin-2-yl]sulfanylacetic acid | —— | C12H18N2O3S |
|
—— | (1S,2R)-1-(2,5-dimethylpyrazol-3-yl)sulfanyl-1-pyridin-3-ylbutan-2-amine | —— | C14H20N4S |
|
—— | (2S)-2-(2,5-dimethylpyrazol-3-yl)sulfanyl-3,3-dimethylbutan-1-amine | —— | C11H21N3S |
|
—— | 2-[4-oxo-1-[(3R)-2-oxopiperidin-3-yl]pyrimidin-2-yl]sulfanylacetic acid | —— | C11H13N3O4S |
|
—— | 2-[4-oxo-1-[(3S)-2-oxopiperidin-3-yl]pyrimidin-2-yl]sulfanylacetic acid | —— | C11H13N3O4S |
|
—— | 2-[1-[(1S,2R)-2-methylcyclopropyl]-4-oxopyrimidin-2-yl]sulfanylacetic acid | —— | C10H12N2O3S |
|
—— | (2R)-3-(2,5-dimethylpyrazol-3-yl)sulfanyl-2-(methylamino)propanenitrile | —— | C9H14N4S |
|
—— | 2-[4-oxo-1-[2-[(2R)-oxolan-2-yl]ethyl]pyrimidin-2-yl]sulfanylacetic acid | —— | C12H16N2O4S |
|
—— | [(1R,2R,4R)-2-(2,5-dimethylpyrazol-3-yl)sulfanyl-4-propylcyclohexyl]methanamine | —— | C15H27N3S |
|
—— | 2-[1-[(2S)-2-(dimethylamino)propyl]-4-oxopyrimidin-2-yl]sulfanylacetic acid | —— | C11H17N3O3S |
|
—— | (1S,2R)-1-(2,5-dimethylpyrazol-3-yl)sulfanyl-1-thiophen-2-ylbutan-2-amine | —— | C13H19N3S2 |
|
—— | (2R)-2-amino-3-(2,5-dimethylpyrazol-3-yl)sulfanyl-2-methylpropanenitrile | —— | C9H14N4S |
|
—— | 1,3-dimethyl-5-[(3S)-pyrrolidin-3-yl]sulfanylpyrazole | —— | C9H15N3S |
|
—— | 2-[4-oxo-1-[2-[(2S)-oxolan-2-yl]ethyl]pyrimidin-2-yl]sulfanylacetic acid | —— | C12H16N2O4S |
|
—— | [(1R,2S)-2-(2,5-dimethylpyrazol-3-yl)sulfanylcyclohexyl]methanamine | —— | C12H21N3S |
|
—— | (2S)-2-[(2,5-dimethylpyrazol-3-yl)sulfanylmethyl]piperidine | —— | C11H19N3S |
|
—— | 1,3-dimethyl-5-[[(3S)-pyrrolidin-3-yl]methylsulfanyl]pyrazole | —— | C10H17N3S |
|
—— | (2S)-2-(2,5-dimethylpyrazol-3-yl)sulfanyl-2-(4-fluorophenyl)ethanamine | —— | C13H16FN3S |
|
—— | (1R)-1-(3-aminophenyl)-2-(2,5-dimethylpyrazol-3-yl)sulfanylethanol | —— | C13H17N3OS |
|
—— | 2-[1-[(3S)-1-methylpyrrolidin-3-yl]-4-oxopyrimidin-2-yl]sulfanylacetic acid | —— | C11H15N3O3S |
|
—— | 1,3-dimethyl-5-[[(2S)-pyrrolidin-2-yl]methylsulfanyl]pyrazole | —— | C10H17N3S |
|
—— | (3S)-3-(2,5-dimethylpyrazol-3-yl)sulfanylpiperidine | —— | C10H17N3S |
|
—— | 1-(2,5-dimethylpyrazol-3-yl)sulfanylcyclooctane-1-carboxylic acid | —— | C14H22N2O2S |
|
—— | (1S)-1-[2-(2,5-dimethylpyrazol-3-yl)sulfanyl-5-fluorophenyl]-N-methylethanamine | —— | C14H18FN3S |
|
—— | (3R)-3-[2-(2,5-dimethylpyrazol-3-yl)sulfanylethyl]piperidine | —— | C12H21N3S |
|
—— | (2S)-1-amino-3-(2,5-dimethylpyrazol-3-yl)sulfanylpropan-2-ol | —— | C8H15N3OS |
|
—— | (1R,2R)-1-(2,5-dimethylpyrazol-3-yl)sulfanyl-1-thiophen-3-ylpropan-2-amine | —— | C12H17N3S2 |
|
—— | (2R)-2-(2,5-dimethylpyrazol-3-yl)sulfanyl-2-methylbutanoic acid | —— | C10H16N2O2S |
|